Mereo Biopharma(MREO.US)

Last Updated 19:00:00 ET
longbridge loading

Cantor Fitzgerald Remains a Buy on Mereo Biopharma Group Plc (MREO)

Tip Ranks·
US
MREO
+0.25%
Tip Ranks·
US
MREO
+0.25%

Mereo BioPharma Shareholders Approve All AGM Resolutions

Tip Ranks·
US
MREO
+0.25%
Tip Ranks·
US
MREO
+0.25%

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading

Fidelity·
US
AKTX
+6.86%
US
NOK
-0.51%
US
EDAP
-2.26%
Fidelity·
US
AKTX
+6.86%
US
NOK
-0.51%
US
EDAP
-2.26%

Mereo Biopharma | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
MREO
+0.25%
Earnings Watch·
US
MREO
+0.25%

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Unusual Whales·
US
MREO
+0.25%
Unusual Whales·
US
MREO
+0.25%

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

Fidelity·
US
MREO
+0.25%
US
CCL
-4.09%
US
SQNS
+1.73%
Fidelity·
US
MREO
+0.25%
US
CCL
-4.09%
US
SQNS
+1.73%

16:59 ETMREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

prnewswire·
US
MREO
+0.25%
prnewswire·
US
MREO
+0.25%
© 2026 Longbridge｜Disclaimer